Skip to content

AKANDA CORP.

AKAN

CIK 0001888014 · Medicinal Chemicals & Botanical Products · Nasdaq

← back to feed
Revenue (TTM)
$836.66K
+97.5% YoY FY Dec 2025
Net Income (TTM)
−$4.1M
+87.3% YoY FY Dec 2025
EPS Diluted (TTM)
−$3.93
+99.3% YoY FY Dec 2025
Gross Margin
24.9%
FY Dec 2025
Operating Margin
-523.8%
FY Dec 2025
Net Margin
-489.6%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$2.53M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
1.98M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings